Two teams independently tease out gene expression patterns in tumor-infiltrating lymphocytes using RNA sequencing

June 27, 2018 by Bob Yirka, Medical Xpress report
T cell
Scanning electron micrograph of human T lymphocyte or T cell. Credit: NIAID/NIH

Two teams working independently of each other have found that it is possible to tease out gene expression patterns in tumor-infiltrating lymphocytes using single-cell RNA sequencing. The first team, based in Australia, sequenced lymphocytes that had infiltrated breast cancer tumors. The second team, based in China, did the same with lymphocytes that had infiltrated lung cancer tumors and surrounding tissue. Both teams describe their findings and results in the journal Nature Medicine.

Lymphocytes are a kind of leukocyte (white blood cell) that tend to exist mostly in the lymphatic system. One particular type is the T cell, which is well known to play a major role in the immune response to foreign material. Cancerous tumors are considered by the immune system to be foreign material, and thus are targeted by T cells and other lymphocytes. Unfortunately, such targeted attacks are not enough to stop many tumors from growing or spreading. In these new efforts, both teams sought to gain a better perspective on which types of immune responses tend to meet with greater success than others. To find out, they conducted single-cell RNA sequencing on lymphocytes involved in such a response—those that had infiltrated tumors.

The team working in Australia focused their study on lymphocytes involved in attacking breast cancer tumors. To that end, they sequenced 6,311 T cells from two major types of breast cancer tumors. Both types of cancer had previously been designated as triple-negative, due to their particular characteristics.

The team in China studied that had infiltrated lung . They sequenced 12,346 single T cells from tumors and from nearby tissue. In their case, the tumors represented 14 distinct types. They also sequenced 8,038 alpha and beta T cell receptors.

In both studies, the researchers report that they were able to tease out . The team in Australia, for example, found that both the quantity and quality of infiltrating T cells can have an impact on the outcome of tumor progression. And the team in China found they were able to track migratory effector T cell clones that actually differed from one tissue to the next.

Both teams suggest that their work shows the potential benefits of understanding single-cell genomics of the microenvironment—the possibility of developing new immunotherapy drugs and techniques.

Explore further: New approach to immunotherapy leads to complete response in breast cancer patient

More information: Peter Savas et al. Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis, Nature Medicine (2018). DOI: 10.1038/s41591-018-0078-7

Xinyi Guo et al. Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing, Nature Medicine (2018). DOI: 10.1038/s41591-018-0045-3

Related Stories

New approach to immunotherapy leads to complete response in breast cancer patient

June 4, 2018
A novel approach to immunotherapy developed by researchers at the National Cancer Institute (NCI) has led to the complete regression of breast cancer in a patient who was unresponsive to all other treatments. This patient ...

Immune response to ovarian cancer may predict survival, study finds

October 12, 2017
A group of international cancer researchers led by investigators from Mayo Clinic and University of New South Wales Sydney has found that the level of a type of white blood cell, called tumor-infiltrating lymphocytes, present ...

T cell channel could be targeted to treat head and neck cancers

November 17, 2016
Researchers at the University of Cincinnati (UC) have discovered that an ion channel, active within T cells (white blood cells), could be targeted to reduce the growth of head and neck cancers.

A new method measures the immune cell response within minutes

May 30, 2018
T cells fight pathogens and tumors: Researchers from the Universities of Tübingen and Lübeck present a simple and fast method to rapidly assess their function.

New screening approach identifies small proteins unique to melanoma cells, researcher says

June 25, 2013
Jamie K. Teer, Ph.D., assistant member of the Cancer Biology and Evolution Program at Moffitt Cancer Center, and colleagues have developed a new streamlined method to rapidly identify the genetic changes in small protein ...

For aggressive breast cancer in the brain, researchers clarify immune response

April 17, 2018
Once it has begun to spread in the body, approximately half of patients with an aggressive breast cancer type will develop cancer in the brain. Researchers at the University of North Carolina Lineberger Comprehensive Cancer ...

Recommended for you

What can salad dressing tell us about cancer? Think oil and vinegar

September 20, 2018
Researchers led by St. Jude Children's Research Hospital scientists have identified another way the process that causes oil to form droplets in water may contribute to solid tumors, such as prostate and breast cancer. The ...

Novel biomarker found in ovarian cancer patients can predict response to therapy

September 20, 2018
Despite months of aggressive treatment involving surgery and chemotherapy, about 85 percent of women with high-grade wide-spread ovarian cancer will have a recurrence of their disease. This leads to further treatment, but ...

New way to target advanced breast cancers

September 20, 2018
A cytokine signature found in certain kinds of breast cancer cells can not only serve as a diagnostic tool for HER2-negative cancers but also offer an effective treatment target.

Testing fluorescent tracers used to help surgeons determine edges of breast cancer tumors

September 20, 2018
A team of researchers with members from institutions in The Netherlands and China has conducted a test of fluorescent tracers meant to aid surgeons performing tumor removal in breast cancer patients. In their paper published ...

Understanding epilepsy in pediatric tumors

September 20, 2018
Pediatric brain tumors are characterized by frequent complications due to intractable epilepsy compared to adult brain tumors. However, the genetic cause of refractory epilepsy in pediatric brain cancer has not been elucidated ...

Researchers find adult stem cell characteristics in aggressive cancers from different tissues

September 19, 2018
UCLA researchers have discovered genetic similarities between the adult stem cells responsible for maintaining and repairing epithelial tissues—which line all of the organs and cavities inside the body—and the cells that ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.